CR20120554A - Combinación de un aine y un aminoácido - Google Patents

Combinación de un aine y un aminoácido

Info

Publication number
CR20120554A
CR20120554A CR20120554A CR20120554A CR20120554A CR 20120554 A CR20120554 A CR 20120554A CR 20120554 A CR20120554 A CR 20120554A CR 20120554 A CR20120554 A CR 20120554A CR 20120554 A CR20120554 A CR 20120554A
Authority
CR
Costa Rica
Prior art keywords
combination
nsaid
amino acid
composition
pharmaceutically acceptable
Prior art date
Application number
CR20120554A
Other languages
English (en)
Inventor
Pelaez Juan Pablo Senosiain
Paniagua Angelica Arzola
Lopez Enrique Raul Garcia-Salgado
Original Assignee
Senosiain S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44903664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR20120554(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Senosiain S A De C V Lab filed Critical Senosiain S A De C V Lab
Publication of CR20120554A publication Critical patent/CR20120554A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica oral que comprende la combinación de una sal de ibuprofeno o S(+)-ibuprofeno con L-arginina y/o sus sales farmacéuticamente aceptables, adicionalmente, vehículos y/o excipientes farmacéuticamente aceptables; el proceso de fabricación de la composición y el uso de dicha composición con actividad terapéutica sinérgica, indicada para el tratamiento de dolor inflamatorio de moderado a severo, fiebre e inflamación.
CR20120554A 2010-05-04 2012-10-30 Combinación de un aine y un aminoácido CR20120554A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2010004974A MX2010004974A (es) 2010-05-04 2010-05-04 Combinacion de un aine y un aminoacido.

Publications (1)

Publication Number Publication Date
CR20120554A true CR20120554A (es) 2013-02-01

Family

ID=44903664

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20120554A CR20120554A (es) 2010-05-04 2012-10-30 Combinación de un aine y un aminoácido

Country Status (14)

Country Link
US (1) US9186342B2 (es)
AR (1) AR081007A1 (es)
BR (1) BR112012028300A2 (es)
CA (1) CA2798420C (es)
CL (1) CL2012003065A1 (es)
CO (1) CO6592037A2 (es)
CR (1) CR20120554A (es)
DO (1) DOP2012000280A (es)
EC (1) ECSP13012765A (es)
ES (1) ES2424417B1 (es)
GT (1) GT201200295A (es)
MX (1) MX2010004974A (es)
PE (2) PE20130316A1 (es)
WO (1) WO2011138653A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3996699T1 (sl) 2019-07-09 2023-10-30 Farmalider, S. A. Kombinacija ibuprofena in tramadola za lajšanje bolečine
MX393732B (es) * 2019-09-06 2025-03-19 Alparis Sa De Cv Compuestos de curcumina y aminoácidos básicos.
US11969400B2 (en) * 2021-03-23 2024-04-30 Kumara V. Nibhanipudi Ibuprofen for symptomatic treatment of diarrheas in HIV patients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US6727286B2 (en) * 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
JP5185488B2 (ja) 2001-11-02 2013-04-17 カンバーランド ファーマシューティカルズ，インコーポレーテッド ２−（４−イソブチルフェニル）プロピオン酸の医薬組成物
CN101889997B (zh) * 2010-07-26 2012-10-03 石家庄中硕药业集团有限公司 一种注射用的含有布洛芬的药物组合物

Also Published As

Publication number Publication date
RU2012151921A (ru) 2014-06-10
ECSP13012765A (es) 2013-09-30
BR112012028300A2 (pt) 2016-11-01
CA2798420C (en) 2018-06-05
US9186342B2 (en) 2015-11-17
AR081007A1 (es) 2012-05-30
US20130109754A1 (en) 2013-05-02
WO2011138653A1 (es) 2011-11-10
DOP2012000280A (es) 2012-12-31
CL2012003065A1 (es) 2013-01-11
PE20170136A1 (es) 2017-03-05
GT201200295A (es) 2014-01-03
CO6592037A2 (es) 2013-01-02
MX2010004974A (es) 2011-11-23
CA2798420A1 (en) 2011-11-10
ES2424417B1 (es) 2014-11-26
ES2424417A2 (es) 2013-10-01
ES2424417R1 (es) 2013-12-20
PE20130316A1 (es) 2013-03-17

Similar Documents

Publication Publication Date Title
AR080491A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
BR112012008317A2 (pt) produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal
AR082167A1 (es) Formas de dosificacion gastrorretentivas
CR20120605A (es) Formulación tópica para un inhibidor de jak
AR091876A1 (es) Combinaciones farmaceuticas para el tratamiento de enfermedades proliferativas
ECSP13012467A (es) Uso de aglutinantes para fabricar formulaciones estables al almacenamiento
MX2024006689A (es) Sales monoacidas de 6-aminoisoquinolinas y usos de las mismas.
AR086356A1 (es) Combinacion farmaceutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2
MX350666B (es) Composiciones y sus usos para tratar hiperuricemia y trastornos metabolicos asociados con hiperuricemia.
NZ602029A (en) Use of meloxicam for the long-term treatment of kidney disorders in cats
EA201491039A1 (ru) Комбинации диацереина и нестероидных противовоспалительных лекарственных средств
BR112014023423A2 (pt) terapia de combinação
BR112014014795A2 (pt) sistema de pélete de multiunidade de liberação imediata
AR050783A1 (es) Agentes terapeuticos con sal de nsaid y paracetamol
UY35091A (es) Formulaciones de liberacion modificada para oprozomib
MX2015012109A (es) Composicion farmaceutica oral de sales sulfato para comprimidos de uso dual y metodos para su uso.
CO6592037A2 (es) Combinación de un aine y un aminoacido
CL2012003119A1 (es) Composicion farmaceutica para inyeccion que compende una solucion acuosa de ibuprofeno y trometamol, en que la concentracion de ibuprofeno esta entre 2 y 6 mg/ml, la concentracion de trometamol esta entre 1.8 y 5.8 mg/ml, y el ph esta entre 7,0 y 9,5; y su uso para el tratamiento del dolor, la inflamacion o la fiebre.
UY31826A (es) Compuesto peptídico y su uso
CY1123933T1 (el) Σκευασματα παρατεταμενης αποδεσμευσης λοραζεπαμης
CL2007000485A1 (es) Sal de alisquereno; procedimiento de preparacion; composicion farmaceutica que comprende a dicha sal; y uso del compuesto para el tratamiento de enfermedades que puedan ser moduladas mediante la inhibicion de la renina.
MX387263B (es) Composición farmacéutica de liberación prolongada que comprende cisteamina o sal de la misma.
BR112014030288A8 (pt) composição farmacêutica, uso da mesma, e, uso de metanossulfonilacetonitrila
BR112015004115A2 (pt) composições farmacêuticas compreendendo flurbiprofeno
AR077451A1 (es) Utilizacion de benzidamina en el tratamiento de enfermedades dependientes de p40